This page has been archived and is no longer updated. We apologize for the inconvenience. To find similar material or an updated version of the page, please visit one the following resources:
Health Topics || Country Sites || News Releases || Our New Homepage

Esta página ha sido archivada y ya no es actualizada. Pedimos disculpas por la molestia. Para encontrar material similar o una versión actualizada de la página, visite uno de los siguientes recursos:
Temas de salud || Sitios de países || Comunicados de prensa || Nuestra nueva página de inicio

What is RAVREDA? 

The Amazon Network for the Surveillance of Antimalarial Drug Resistance (RAVREDA) refers to the network organized in 2001 by Bolivia, Brazil, Colombia, Ecuador, Guyana, Peru, Suriname, and Venezuela, along with PAHO, in response to the challenge of antimalarial drug resistance in the Amazon. As its work progressed, RAVREDA partnered with international institutions and local organizations in the countries to achieve its goals, which have now been expanded to include the various components of the Strategy and Plan of Action for Malaria, as aligned with national and global strategies and goals. The network was expanded in 2008 to include Panama, Nicaragua, Honduras, Guatemala and Belize in Central America. French Guiana, Haiti and Dominican Republic currently join the network as observers.

The Amazon Malaria Initiative (AMI) was launched in 2001 by the United States Agency for International Development, Office for Infectious Diseases in Latin America and the Caribbean (USAID/LAC), as its mechanism for focusing its financial and technical resources in support of the Roll Back Malaria Partnership in Latin America. With strong emphasis on the importance of promoting coordination of efforts among all partners in the Region, AMI was implemented by five USAID partners: PAHOCDCMSH, USP/PQM, and Links Media.

pdf Presentation on RAVREDA/AMI  (In Spanish only)